HBV-IN-14
Modify Date: 2025-08-27 15:06:59
HBV-IN-14 structure
|
Common Name | HBV-IN-14 | ||
|---|---|---|---|---|
| CAS Number | 2712529-19-4 | Molecular Weight | 428.87 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H21ClN2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HBV-IN-14HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection (extracted from patent WO2021190502A1, compound 5)[1]. |
| Name | HBV-IN-14 |
|---|
| Description | HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection (extracted from patent WO2021190502A1, compound 5)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Lifang Wu, et al. Pyridopyrimidinones. Patent WO2021190502A1. |
| Molecular Formula | C22H21ClN2O5 |
|---|---|
| Molecular Weight | 428.87 |